TLC to Present at the 42nd Annual JP Morgan Healthcare Conference
December 27, 2023 05:40 ET
|
TLC
TLC BioSciences to Present at 42nd Annual JP Morgan Healthcare Conference in San Francisco
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023 16:31 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
Syneos Health to Present at the 37th Annual J.P. Morgan Healthcare Conference
December 18, 2018 16:53 ET
|
Syneos Health
MORRISVILLE, N.C., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research...
Sera Prognostics to Present at 35th Annual J.P. Morgan Healthcare Conference
January 03, 2017 10:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...